Objective: The aim of this study was to determine sucralose and acesulfame-potassium (ace-K) pharmacokinetics in breast milk following maternal ingestion of a diet soda. Methods: Thirty-four exclusively breast-feeding women (14 normalweight, 20 obese) consumed 12 ounces of Diet Rite Cola, sweetened with 68-mg sucralose and 41-mg ace-K, before a standardized breakfast meal. Habitual non-nutritional sweeteners intake was assessed via a diet questionnaire. Breast milk was collected from the same breast before beverage ingestion and hourly for 6 hours. Results: Owing to one mother having extremely high concentrations, peak sucralose and acesulfame-potassium concentrations following ingestion of diet soda ranged from 4.0 to 7387.9 ng/mL (median peak 8.1 ng/mL) and 299.0 to 4764.2 ng/mL (median peak 945.3 ng/mL), respectively. Conclusions: Ace-K and sucralose transfer into breast milk following ingestion of a diet soda. Future research should measure concentrations after repeated exposure and determine whether chronic ingestion of sucralose and acesulfame-potassium via the breast milk has clinically relevant health consequences.
I n utero and early life exposures influence infant taste preferences and eating behavior (1) , and may impact long-term weight trajectory and health (2) . We have previously reported that nonnutritive sweeteners (NNS) such as sucralose, acesulfame-potassium (ace-K), and saccharin were present in breast milk of 20 lactating women measured randomly at a single time-point (3). Aspartame was not detected, which is expected since it is immediately metabolized in the gut. With the exception of saccharin, which is not recommended for consumption during pregnancy, NNS are regarded as safe during pregnancy and lactation. Thus, it can be assumed that a large number of infants are exposed in utero and while nursing (3, 4) . Given the innate preference for sweetness (1) and the known modulation of infant taste preferences by flavors to which they are repeatedly exposed (5) , ingestion of NNS in breast milk may promote greater liking of sweet tasting foods and beverages. As the predominant sugar in breast milk is lactose, which has a relatively low sweet taste intensity, addition of NNS to breast milk may possibly enhance its sweetness and thus encourage overconsumption. In fact, previous studies demonstrate that infants consume larger volumes of sweetened substances (6) .
Beyond potentially influencing infant taste preferences, future food choice, and appetite regulation, early life NNS exposure may also influence the child's metabolism and future health (4) .
What Is Known
In utero and early life exposures influence infant taste preferences and eating behavior and may impact long-term weight trajectory and health. Non-nutritive sweeteners such as sucralose, acesulfame-potassium, and saccharin are present in human breast milk.
What Is New
Acesulfame-potassium was rapidly transferred into breast milk following maternal ingestion of a diet soda, whereas sucralose appeared 2 hours following ingestion. Non-nutritional sweetener concentrations in breast milk varied markedly between individuals. Concentrations of sucralose were higher in normalweight compared with obese mothers, but this difference disappeared after adjustment for blood volume.
See ''Splenda in the Milk: Hitting the Sweet Spot'' by Lee Couper and Couper on page 371.
NNS use in children and adults has been associated with obesity and metabolic abnormalities in epidemiologic studies (7) , and a causal link between NNS, weight gain, and glucose intolerance has been demonstrated in rodents (8) . If similar findings were demonstrated in humans, this would have critical implications for the developing infant, as exposure to other dietary constituents early in life, such as phthalates and bisphenols (9) , exerts a lasting influence on child cardiometabolic outcomes. Furthermore, NNS have been shown to alter the gut microbiome in rodents (8) and in a small human study (8) . This is important, as the gut microbiome has emerged as an important mediator in immunity, inflammation, and metabolic disease (10) .
Despite the ongoing debate about NNS effects, their consumption has continued to increase and is particularly prevalent among females and individuals with obesity (11) . However, no data on the pharmacokinetics of NNS in breast milk are available. Therefore, this study aimed to evaluate the pharmacokinetics of sucralose and ace-K following maternal ingestion of a diet soda and to determine whether breast milk NNS concentrations differed in normal weight compared to obese mothers.
METHODS
A total of 34 exclusively breast-feeding women (14 normalweight, 20 obese) and their infants who were approximately 6 weeks postpartum were enrolled. The protocol was approved by the institutional review board at the University of Oklahoma Health Sciences Center and written informed consent was obtained in all mothers before testing (NCT #02940795).
NNS intake was assessed using a short food frequency questionnaire. Dietary intake and physical activity during the 24 hours before the study visit were recalled and recorded by the participant. Maternal weight was measured using a digital scale and standing height was measured using a standard stadiometer. Body mass index (BMI) was calculated (kilograms per square meters) and weight status was determined using standard BMI cut-offs.
Participants were provided with a breast pump and collection containers for use during the study and detailed instructions for sample collection, storage, and transport. The day before testing, participants were asked to refrain from all soda, fruit juice, and candy. Participants fasted overnight and provided a baseline breast milk sample at 6:00 AM. Thereafter, women consumed 12 ounces of Diet Rite Cola (caffeine free, commercially available diet soda containing 68-mg sucralose and 41-mg ace-K) before a standard breakfast meal (Jimmy Dean Breakfast Bowl Turkey Sausage breakfast). Participants then provided breast milk from the same breast hourly for 6 hours. Samples were immediately frozen after collection and were either delivered to the research team in an ice cooler or stored frozen in the home until pick-up by a study team member.
Sucralose and ace-K concentrations in the breast milk were measured in triplicate using liquid chromatography-mass spectrometry. Analyses were performed with an Acquity I-Class UPLC (Waters Corp., Milford, MA) and an Acquity UPLC BEH C-18 column (2.1 mm Â 50 mm, 1.7 mm) coupled with a Q-Exactive MS (Thermo Scientific, Waltham, MA) with a HESI-II electrospray source. All analyses were performed using isotopically labeled sucralose as the internal standard for sucralose measurements and isotopically labeled ace-K for ace-K measurements. The coefficient of variation for the samples within day was 4.5% for sucralose and 0.8% for ace-K, respectively, and for samples between days was 5.8% for sucralose and 1.0% for ace-K, respectively.
Descriptive statistics were conducted for concentrations of both sweeteners, as well as demographic and anthropometric characteristics of the mothers and infants. The total area under the curve (AUC) was calculated using the trapezoidal method. The peak for both sucralose and ace-K was calculated as the maximum value during the 360-minute time course. Given that blood volume is greater in obese versus lean individuals (12) , adjustments for blood volume were performed. We multiplied each subject's breast milk sucralose or ace-K concentrations by their blood volume, which we estimated using a validated equation (12) . Differences based on weight status and NNS consumption were assessed using paired t tests and 1-way analysis of variance, respectively. P values <0.05 were considered statistically significant.
RESULTS
Demographic data are shown in Table 1 . The majority of participants were non-Hispanic white. The distribution of age and race/ethnicity was similar across the normal-weight (n ¼ 14) and obese (n ¼ 20) mothers. Among 19 infants with demographic and/or anthropometric information available (infant data were only available if the infants participated in other studies, as the present study was a milk pharmacokinetics study), 89% (17/19) were non-Hispanic white and 81% (13/16) were males. Mean infant birth weight was 3.5 AE 0.4 kg and mean gestational age was 39.4 AE 1.0 weeks.
Thirty-nine percent of mothers reported never or rarely consuming NNS, whereas 36% and 24% reported weekly and daily consumption, respectively. Only 2 mothers reported consumption of Splenda packets, in which sucralose is the active ingredient. Seventy-six percent of mothers reported never or rarely consuming foods containing NNS (which typically are sweetened with sucralose and/or ace-K), whereas 12% reported weekly and 12% reported daily consumption of NNS containing foods. Reported NNS use was similar among normal-weight and obese mothers.
At baseline, before ingestion of the diet soda, sucralose and ace-K were detected in the breast milk of 21% (0.4-5.2 ng/mL sucralose) and 18% (11.9-733.2 ng/mL ace-K) of mothers, respectively. Owing to 1 mother having extremely high concentrations, peak sucralose concentrations following ingestion of diet soda ranged from 4.0 to 7387.9 ng/mL/360 min (median peak 8.1 ng/mL/360 min) and the AUC ranged from 526.1 to 2,337,351 ng/mL (median AUC 1244.2 ng/mL/360 min). Peak ace-K concentrations ranged from 299.0 to 4764.2 ng/mL/360 min (median peak 945.3 ng/mL) and the AUC ranged from 46,396.7 to 1,466,799 ng/mL (median AUC 218,885.1 ng/mL/360 min). Median values and interquartile ranges for sucralose and ace-K at each time point, along with peaks and AUCs, are shown in Table 1 .
In Figure 1A , the time course of the mean NNS concentrations during the 360-minute time course is shown (n ¼ 33), with 1 mother with strikingly high sucralose concentrations shown separately (n ¼ 1). Concentrations of sucralose were higher in normalweight compared to obese mothers (median sucralose peak 9.8 vs 7.6 ng/mL, P ¼ .01 in normal vs obese, respectively) and a similar trend was observed for ace-K (1243.5 vs 876.6 ng/mL, P ¼ 0.14) (Fig. 1B) . However, this trend disappeared after adjustment for blood volume. Concentrations of either sweetener also did not differ based on reported overall NNS consumption, Splenda use, nor NNS-containing food intake.
DISCUSSION
Our findings demonstrate that ace-K and sucralose transfer into breast milk following ingestion of a diet soda. Ace-k was immediately detectable, whereas sucralose appeared in breast milk 2 hours following ingestion, with concentrations varying markedly between individuals. Given that ''real-life" NNS consumption often occurs on multiple occasions during the course of several days, concentrations reported in the current analysis may underestimate true infant exposure via the breast milk. Ace-K concentrations peaked approximately 4 hours after maternal ingestion of the diet soda, whereas sucralose concentrations continued to rise during the 6-hour time course, suggesting that peak levels had not yet been reached. Compared to plasma concentrations previously determined in adults, ace-K concentrations (13) in breast milk were very similar, but sucralose concentrations were approximately 10-fold lower in breast milk at the 2-hour time point (14) .
There are several potential implications of early life exposure to NNS during lactation (3, 4) . These include alteration of the gut microbiome (8), which is highly dynamic throughout the first 3 years of life and is known to be influenced by diet and nutrition during infancy, among many other factors (15) . In addition to altering gut microbiota, the presence of NNS in breast milk may also alter the composition of human milk oligosaccharides, known to be associated with infant growth and body composition (16) . NNS ingestion has also been proposed to increase the preference for sweet taste (17) , and to promote energy intake (18, 19) , weight gain (18, 19) , and glucose intolerance (20) . Owing to immature drug transporters (eg, P-glycoprotein) and drug-metabolizing enzymes (eg, CYP3A) in neonates (21), ingestion of even small quantities of sucralose (which induces P-gp and CYP3A in rodents (18)) may lead to higher NNS concentrations in the infants' bloodstream than in adults. Given that the threshold of NNS required to exert metabolic and health effects is unknown, whether rapid sucralose and ace-K appearance in breast milk following maternal ingestion of diet soda plays a clinically relevant role in infant diet and health requires further study.
Limitations of this study include the small sample size, inclusion of NNS consumers and nonconsumers, and inability to quantify intake of specific NNS among NNS-consumers. Furthermore, no maternal plasma was obtained, and thus, plasma sucralose and ace-K concentrations were not measured. Comparisons Ace-K ¼ acesulfame-potassium; BMI ¼ body mass index; NNS ¼ non-nutritive sweeteners; SD ¼ standard deviation. Ã Indicates statistically significant difference between normal-weight and obese mothers based on a P value <0.05. When excluding the one outlier, ID #206, there were no statistical differences in breast milk concentrations between normal weight and obese mothers.
y Not all percentages for NNS consumption add up to 100% owing to rounding.
between breast milk and blood concentrations could only be based on historic data. In addition, 6 hours of measurement for was not sufficient to achieve peak sucralose concentrations and no information on infant NNS concentrations or infant health outcomes was collected. Study strengths include serial NNS measurements and the inclusion and comparison of normal weight and obese mothers. Although the current analysis assessed NNS concentrations following a single diet soda ingestion, future research should determine NNS concentrations after repeated exposure. Most importantly, these results further emphasize the need to determine whether chronic ingestion of NNS via the breast milk has clinically relevant consequences such as alteration of taste preferences, gut microbiota, metabolism, and weight trajectory.
